Daily Archives: August 14, 2017

ASCAP has named former New York Times digital executive Tristan Boutros as Chief Technology Officer, CEO Elizabeth Matthews announced Monday (Aug. 14). He will be based in New York and report to Executive Vice President & Chief Operating Officer Brian Roberts.

According to a press release, Boutros will lead ASCAPs evolving technology strategy and execution to scale the global IT systems and infrastructure in support of the organizations business-transformation initiatives, encompassing cloud strategy, elastic computing and API roadmap. He was most recently the New York Times chief of operations.

ASCAP CEO Elizabeth Matthews said, We are thrilled to welcome Tristan to the ASCAP team. He brings a unique combination of the understanding of third party technology solutions available in the market as a complement to his technical expertise in building internal solutions. His experience helping top organizations achieve their technology goals make him the perfect person for this role.

I am excited to have the chance to create an incredibly robust platform at ASCAP, developing the tools and experiences that further empower our members and licensees; and change the way they work, communicate, and receive payment, said Boutros. I look forward to working with the whole team at ASCAP to bring this future to our members, and to unlock new capabilities for all of us.

Prior to the New York Times, Boutros spent three years as senior vice president of technology and business process at Warner Music Group. He has also held senior technology roles at BlackBerry and IAC. He is also an adjunct professor of computer science at Columbia University and co-author of several books.

Read the original:

ASCAP Names Tristan Boutros Chief Technology Officer - Variety

Nearly every major technology reform bill has followed a similar path over the last 30 years. After being introduced as standalone legislation, lawmakers eventually attach it as an amendment to the defense authorization bill.

It seems the Modernizing Government Technology (MGT) Act is heading down the same well-traveled trail.

Sens. Jerry Moran (R-Kan.) and Tom Udall (D-N.M.) have filed an amendment to the NDAA bill that is the MGT Act.

I am very hopeful that the Senate Homeland Security and Government Affairs Committee will take up the MGT Act soon after the August recess, Udall said in an email to Federal News Radio. There have been constructive, bipartisan conversations between the bill sponsors, committee leaders and the administration, and I believe we can come together and move the bill through the Senate in the coming months. To that end, I joined Sen. Moran in filing the MGT Act as an amendment to the NDAA since that may again be a viable path towards enacting important federal IT reform legislation.

Sponsored Content: How is your agency managing and maximizing its data? Share your opinions in a Federal News Radio survey.

One industry source said Sen. Ron Johnson (R-Wis.), the chairman of the Homeland Security and Governmental Affairs Committee, still must approve or at least not object to any path MGT will take to becoming law.

The amendment seems to mirror the Houses version of MGT, which passed May 17 by voice vote.

A HSGAC spokeswoman told Federal News Radio that the committee staff continues to review the bill.

The news that Moran and Udall filed MGT Act as an amendment was seen as a positive development by industry observers.

We welcome this addition to the National Defense Authorization Act, which traditionally has been a major vehicle for significant IT policy reforms, said Rich Beutel, president of Cyrrus Analytics and a former House staff member. This forward-looking provision will create a virtuous cycle of agency innovation driving home the promise of IT modernization across the federal government.

GSA gives per diem travel rates another bump for 2018

Mike Hettinger, managing principal of Hettinger Strategy Group LLC and a former House staff member, said: MGT has been a top industry priority since its introduction last year and we are encouraged to see it potentially move forward as part of the NDAA. Getting this bill enacted, whether as a standalone or as part of the NDAA is a critical step to kick-starting governments IT modernization.

Starting with the Clinger-Cohen Act of 1996, to the Services Acquisition Reform Act, to the Federal IT Acquisition Reform Act, using the NDAA is almost the only way to get governmentwide legislation passed. The E-Government Act of 2002 and the Federal Information Security Management Act of 2002 are two of the most recent examples of bills that got through Congress and to the president without the benefit of the NDAA.

The House passed its version of the NDAA on July 14, while the Senate has moved its version out of committee, but not to the floor for consideration.

Several other senators are planning to introduce acquisition or technology-related amendments on the floor when Congress comes back in session after Labor Day. Some of the most interesting ones include:

The rest is here:

Modernizing Government Technology Act to get second path to passage in Senate NDAA - FederalNewsRadio.com

Wall Street Journal (subscription)

Technology Speeds Up Timeline on Quarterly Close Wall Street Journal (subscription) As accounting becomes more reliant on technology, finance chiefs across a range of sectors are reaping substantial benefits from closing their books faster. Companies including Red Hat Inc., RHT 1.16% Duke Energy Corp. DUK 0.17% and Dun & Bradstreet ... and more »

Follow this link:

Technology Speeds Up Timeline on Quarterly Close - Wall Street Journal (subscription)

The capabilities of gene drive are thrillingand also terrifying.

Michael MechanicAug. 14, 2017 6:00 AM

A gene drive currently in development could render Anopheles stephensi mosquitoes unable to spread malaria.James Gathany/AP

Not long ago, Bill Gates, whose family foundation has spent billions of dollars battling diseases around the globe, noted in his blog that the deadliest animals on the planet are not sharks or snakes or even humans, but mosquitoes. Technically, the bloodsuckers merely host our most dangerous creatures. Anopheles mosquitoes can incubate the protozoae responsible for malariaa stubborn plague that inspired the DDT treatment of millions of US homes and the literal draining of American swampsduring the 1940s to shrink the insects breeding grounds. Malaria is now rare in the United States, but it infected an estimated 212 million people around the world in 2015, killing 429,000mostly kids under five.

Dengue, which infects up to 100 million people worldwide each year, is spread largely by Aedes aegypti mosquitoes, which thrive along our Gulf Coast and alsoare capable of transmitting the related viruses Zika, chikungunya, and yellow fever. Of the millions infected, roughly 500,000 dengue victims develop an excruciatingly painful break-bone feveraccording to Laurie Garretts The Coming Plague, dengue derives from the Swahili phrase ki denga pepo, it is a sudden overtaking by a spiritand tens of thousands die.

West Nile virus, spread by Culex mosquitoes, has killed more than 2,000 Americans since 1999, primarily in California, Colorado, and Texas. Our latest headache, Zika, produces ghastly brain defects in the infants of infected mothers and neurological symptoms in some adults. Puerto Rico has been ravaged by more than 35,000 mosquito-borne Zika cases since 2015, not to mention periodic dengue outbreaks that afflict tens of thousands of people.

What if we could make all of this go away?

We do, in fact, have a weapon that could end the mosquitos reign of terror. Its called gene drive, and its implications are thrillingand also kind of terrifying.

Evolution is a numbers game. Say you were to engineer a lab-modified gene into an animal embryo. By the rules of inheritance, that anomaly would be passed along to roughly half the creatures offspring. Assuming the new gene didnt offer any survival advantage (or disadvantage), it would be inherited by about a quarter of the subsequent generation and then an eighth and a sixteenth, and so onuntil it became the genetic equivalent of radio static.

Gene drive upends that calculus. Lab-tested so far in yeast, fruit flies, and mosquitoes, this powerful new technique guarantees that a modified genetic trait is inherited by virtually all a creatures offspring and all theiroffspring. After a while, every individual in the population carries the modification.

This wouldnt work in people, thankfullya short reproductive cycle and plenty of offspring are required for gene drives to spread effectively. But one could build, for instance, a drive targeting Aedes mosquitoes that leaves their offspring unable to reproduce, or one that makes Anopheles mosquitoes unable to transmit malaria. You could design a drive to control a stubborn crop pest or to render white-footed mice incapable of acting as a vessel by which ticks pick up and spread Lyme disease.

If used with care, gene drive could save millions of lives and billions of dollars. It could reduce pesticide use, help weed out nasty invasive species, and prevent tremendous human suffering. Then again, it could have unintended social and ecological consequencesor be hijacked for malevolent purposes.

The concept of gene drive, based on naturally occurring selfish genes that can copy themselves around a genome, has been around for decades. In a 2003 paper, the British geneticist Austin Burt suggested that harnessing this ability and improving upon it would allow scientists to engineer natural populations, with an eye, for instance, toward preventing the spread of malaria.

Burts insight wasnt practical, though, prior to the fairly recent invention of a breakthrough technique called CRISPR-Cas9 gene editing. With this innovation, a scientist uses customized ribonucleic acid (RNA) guide sequences to deliver a molecular scissors (an enzyme called Cas9) to a precise spot on a chromosome. The enzyme snips the double helix, prompting the cells DNA-repair machinery to kick in and patch things upand in the process replacing the wild-type gene at that location with a lab-engineered DNA sequence. (Heres one simple diagram.)

One spring day in 2013, about a decade after Burts paper appeared, a 30-year-old researcher named Kevin Esvelt was out walking in the Boston-area greenbelt known as the Emerald Necklace, pondering his next move. Esvelt, a post-doctoral fellow working with the renowned Harvard geneticist George Church, had ruled out working on the development of new CRISPR techniques. The field had become so crowded, he recalls via email, it seemed likely almost anything I tried would be pursued by at least three other labs.

Kevin Esvelt in his laboratory.

MIT Media Lab

As he walked along, Esvelt idly wondered whether any of the greenbelts wild creatures would end up being gene-edited in the decades to come. You could do it, of course, by introducing the CRISPR elements into wild-animal embryos. But why bother? The modified genes would become less and less prevalent with each generation of offspring. Natural selection would eventually weed them out of the population entirely.

And thats when it hit him: Scientists had been putting the CRISPR tools into their target cells as separate pieces. What if you introduced them into the embryos as a single, heritable element? Those creatures and their descendantsall of themwould retain the gene-editing ability in their DNA. The system would be self-propagating. In short, you could rig natures game so your gene would win every time!

Esvelt was practically giddy with the possibilities. The first day was total elation, he told me. He found Burts paper and began fantasizing about all the lives gene drive might save. But the elation didnt last long. A mistakeor a deliberate acthe soon realized, would alter an entire species. An experimental drive could escape into the wild before society agreed that it was okay. Perhaps gene drive could even be used as a weapon of sortsa means for sowing havoc. Once it hit me, he recalls, well, there was a flash of pure terror, followed by an obsessive evaluation of potential misuses. Like Enrico Fermi, the scientist who demonstrated the first nuclear chain reaction back in 1942Esvelt would be letting a very big cat out of the bag.

He took his ideas and concerns to his mentor, George Church. A scientists usual first instinct is to test an exciting hypothesis right away to see whether its viable, and then be the first to press with a blockbuster paper. This felt different. We decided not to immediately test it in the labnot because we couldnt do it safely, but because we felt that no technology like this should be developed behind closed doors, Esvelt says. The question was whether it was safe to tell the world. At Churchs urging, they brought on Jeantine Lunshof, an ethicist, and Ken Oye, a social scientist and policy expert: Kens first words after I described the probable capabilities were not publishable.

The researchers determined that their best course was to go public before doing any experiments. They solicited feedback from fellow molecular biologists, ecologists, risk analysts, public policy and national security experts, and representatives of environmental nonprofits. Only then, in July 2014, did they publish a pair of papers on gene drives uses and policy implications.

This summer, a group of researchers that consults for the federal government was tasked with analyzing the techniques potential risksincluding the possibility that it could be used for biowarfare. The range of nefarious possibilities based on genetically engineered microorganisms is already vast, Steven Block, an expert in bioterror defense at Stanford University, told me in an email. The right question to ask is whether a hypothetical gene-drive-based bioweapon, which is based on multicellular organisms, would afford any specific advantages over something based on microorganisms. Would it be more powerful? Cheaper? Easier to construct? Would it be more accessible to an adversary? Would it afford any special desirable properties as a weapon, from either a strategic or tactical perspective? Id argue that, at least for the time being, gene drive seems to have done little to change the lay of the land.

Accidents, mistakes, and unsanctioned releases are a separate concern. But Esvelt and his peers realized, to their great relief, that gene drives can be overwritten; they spread slowly enough through a population and are easy enough to detect, Esvelt says, that researchers should be able to stop a rogue drive using something called an immunizing reversal drive that can cut up the engineered sequence and restore the original genes. (He and Church have demonstrated the reversal process in yeast.) In any case, he says, it would be difficult to imagine any possible combination of side-effects worse than a disease like malaria.

Over the past couple of years, several labs have proved that gene drives work as hypothesized. The next step is to convince society they can be tested safely. Each drive is different, so potential risks and benefits have to be weighed on a case-by-case basis. But one big-picture problem is that wild creatures dont respect human boundaries. A drive could easily scamper or fly or tunnel across borders and into areas where it hasnt been sanctioned by local authorities. And that, Esvelt says, could trigger international disputes or even wars.

In his new position as head of the Sculpting Evolution group at the Massachusetts Institute of Technologys Media Lab, Esvelt is working on gene-drive variations that can limit the spread of the engineered genes to a given number of generations. But diplomacy will be needed regardless. For malaria, the case for an international agreement is obvious, Esvelt says. Ditto the New World screwworm, whose existence in the wild is an atrocity from an animal welfare perspectiveit literally exists by eating higher mammals alive, causing excruciating agony.

In 2015, Austin Burt and his collaborators unveiled a gene drive designed to decimate populations of the African malaria mosquito Anopheles gambiae by rendering all female offspring sterile, although for statistical reasons, it is quite implausible for a gene drive system to completely wipe out a problematic species, Esvelt says. Suppress a population, sure. Locally eliminate, possibly. But extinction? Not by itself.

Anthony James, a geneticist at the University of California-Irvine, opted to target the disease directly. In 2015, he and his colleagues lab-tested a drive that enlists a pair of synthetic antibodies to disable malaria in the gut of the South Asian mosquitoAnopheles stephensi. The dual attackwhich targets two distinct phases of the parasites life cycleshould be all but impossible for the organism to overcome. In the highly unlikely event that these antibodies were to get into another insect species, they shouldnt cause any problems. And because the mosquito population remains intact, their predators wont lack for food.

James says his malaria drive will be ready for field tests within two yearseither in huge outdoor cages or within a naturally confined environment such as an island. But is humanity ready to allow it? Its all new stuff. This is the problem. Theres no pathway, he says. Securing permission to move forward with testing will depend entirely on the local mood and regulatory situation. As for deploying gene drive on a species-wide scale? Esvelt is skeptical that nations would accept wild releases without constraints in place that would limit their scope.

One way or the other, something has to change on the mosquito front. Conventional control methodsmonitoring and education, poisons, door-to-door efforts to eliminate standing waterarent working. Poor countries in particular lack the resources to keep the bugs at bay, and because insects and microorganisms evolve so rapidly, our chemical weapons are rapidly losing their effectiveness. According to Bill Reisen, a retired UC-Davis mosquito expert, California mosquitoes can now tolerate compounds from three major families of insecticides that were once used to kill them: The opportunities for control are becoming progressively limited. The Centers for Disease Control and Prevention reports that Plasmodium falciparum, the worlds deadliest malaria parasite, has developed resistance to nearly all antimalarial drugs.

A Zika vaccine seems to be on the horizon, but dengue remains a frustratingly elusive target for vaccine developers. UC-Davis geneticist Greg Lanzaro told me last year that, were it solely up to him, he would deploy gene drive as soon as scientifically feasible to beat back the Aedes mosquitoes that spread these diseases. Esvelt has heard similar sentiments from peers in several fields. As a scientist, its hard to accept nontechnical limitations, especially when we could seemingly save so many lives if those constraints somehow magically vanished, he says. But they wont.

One thing is for sure: The first effort has to be an unqualified success, James says. If theres a trial and its a disastermeaning it doesnt prevent an epidemicthe technology is going to be set back. Esvelt points to Jesse Gelsinger, an 18-year-old whose death during a 1999 gene therapy trial stifled progress in that field for a decade or more. An accident involving a CRISPR gene drivewhich would be viewed as reckless scientists accidentally turning an entire species into GMOswould almost certainly have similar effects, he says. And in the case of malaria, the delay would likely result in the otherwise preventable deaths of millions of children.

So hes willing to wait to get it right. Indeed, in Esvelts view, gene drive is so existentially powerful that it demands a new era of scientific transparency. If researchers dont rethink their longtime custom of competing behind closed doors, we are likely to open extremely dangerous technological boxes without even realizing it. A deeply collaborative approach with preregistered experiments,he says, would help scientists identify unforeseen dangers and ensure that those boxes remain closed until we can develop countermeasures. Such a radical departure from the current culture of secrecy would require nothing short of a sea change in the scientific community. But it might be worth the effort. As Esvelt puts it, The greatest potential application of gene drive is to engineer the scientific ecosystem.

Correction: Austin Burt was not the first to describe gene drive. It was he who suggested that it could be used to alter natural populations.

Mother Jones is a nonprofit, and stories like this are made possible by readers like you. Donate or subscribe to help fund independent journalism.

Originally posted here:

This Technology Could Stop the World's Deadliest Animal - Mother Jones